Skip to content
Use caution Drug recall · FDA · Published March 1, 2010

K C Pharmaceuticals Eye Drops Recall: Label Mix-Up Hazard

K C Pharmaceuticals recalls Eye Drops Advanced Relief due to incorrect back labeling missing active ingredients. Check your lot number and expiration date.

🇺🇸 FDA recall #D-192-2013DrugK C Pharmaceuticals ›
Take action

Contact the company

Recalling firmK C Pharmaceuticals Inc3201 Producer Way · Pomona, CA 91768-3916
✎ GovInfoNow plain-language explainer

K C Pharmaceuticals Inc has recalled Eye Drops Advanced Relief because the back of the immediate container is incorrectly labeled. The label fails to list three active ingredients: Dextran 70, Polyethylene glycol 400, and povidone. This labeling error means users may not be aware of all components in the solution. Read more at govinfonow.com/recall/48997-k-c-pharmaceuticals-inc-recalls-eye-drops-advanced-relief-dextran.

Source Summary by GovInfoNow · govinfonow.com/recall/48997-k-c-pharmaceuticals-inc-recalls-eye-drops-advanced-relief-dextran · Updated October 13, 2026 · FDA enforcement record: FDA #D-192-2013

Cite this page

“K C Pharmaceuticals Eye Drops Recall: Label Mix-Up Hazard.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48997-k-c-pharmaceuticals-inc-recalls-eye-drops-advanced-relief-dextran. Based on FDA recall #D-192-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-192-2013%22&limit=1).

K C Pharmaceuticals Inc recalled Eye Drops Advanced Relief on March 1, 2010, due to incorrect back labeling that omitted three active ingredients, according to the FDA. The Food and Drug Administration announced the Class II recall affecting 31,704 bottles distributed nationwide.

How to tell if you have it

  • Brand: K C Pharmaceuticals
  • Product: Eye Drops Advanced Relief
  • Active Ingredients: Dextran 70 0.1%, Polyethylene glycol 400 1%, Povidone 1%, Tetrahydrozoline HCl 0.05%
  • Size: 1/2 fl oz (15 mL) bottle
  • Distributed By: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37072
  • Lot #: 9P367
  • Expiration Date: 12/12
  • Units Affected: 31,704 bottles

The hazard

The immediate container's back labeling was incorrect and did not list three active ingredients: Dextran 70, PEG 400, and povidone. The front label and unit carton were correct.

Context

GovInfoNow's records show K.C. Pharmaceuticals, Inc has 4 other recalls on record since 2014-12-04. Other recent recalls of similar products include Eye Drops MAXIMUM (2026-09-11), Ultra Lubricating Eye Drops (2026-03-03), and Original Eye Drops (2023-06-13). Other recent recalls of similar products include Buprenorphine Tablets (2026-08-19), Levocarnitine Injection (2026-04-16), and Tropicamide Eye Drops (2025-11-20).

How to tell if you have this one

Look for Eye Drops Advanced Relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povidone 1%, Tetrahydrozoline HCl 0.05%) in a 1/2 fl oz (15 mL) bottle. Check the lot number for 9P367 and the expiration date of 12/12. The product was distributed by Dolgencorp, LLC.

  • Brand
    K C Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product

    Verify if your eye drops match the recalled lot number 9P367 and expiration date 12/12.

  2. Contact Dolgencorp

    Since the remedy is not stated in the record, contact Dolgencorp, LLC for further instructions on how to proceed with this specific recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.1 years after the firm started it.

1. Firm started the recall: Mar 1, 201012. FDA classified it Class II: Mar 8, 201323. Published in FDA’s Enforcement Report: Mar 20, 201334. FDA terminated the recall: Apr 2, 2013420102013
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-192-2013 (March 1, 2010) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-192-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA